Thoratec and HeartWare International are disappointed with the FTC’s decision to challenge the acquisition. The companies intend to review the FTC’s decision and mutually assess the appropriate next steps and promptly communicate their intentions to the market once a decision has been made.

HeartWare International develops and manufactures miniaturized implantable heart pumps

Thoratec is a company engaged in developing therapies to address advanced-stage heart failure.